IRLAB to Present Data from the Phase IIb Study of Mesdopetam

20.06.2023 - GOTHENBURG, SE / ACCESSWIRE / June 20, 2023 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, June 20, 2023 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel treatments for Parkinson's ...

Related Keywords

Sweden , Arvid Carlsson , Gunnar Olsson , Movement Disorder Society , International Congress , Movement Disorders Society , International Parkinson , Movement Disorders , Placebo Controlled Phase , Study Evaluating , Daily On Time , Troublesome Dyskinesia , Exhibition Hall , Nobel Laureate , Integrative Screening Process , Nasdaq Stockholm ,